DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2

DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2, also known as DOTA-E[c(RGDfK)]2, is a radiolabeled peptide-based compound used in molecular imaging and targeted therapy. It is a specific molecule designed to target integrin receptors, which are proteins found on the surface of cells, often overexpressed in tumors and involved in processes such as tumor growth, angiogenesis, and metastasis.

msds of DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2